Company: DVAX
Filing Date: 2025-04-15
Form Type: PRER14A
Source: 0000930413-25-001254
Chunk: 96

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-15
Form: PRER14A
Chunk 96
---
, performance stock awards and other stock awards exclusively to individuals 
 who were not previously employees or directors of the Company, or who had experienced a bona fide period of non-employment,          
 as an inducement material to the individual’s entry into employment with us within the meaning of Nasdaq Marketplace                 
 Rule 5635(c)(4). The terms of awards under the 2021 Inducement Plan are substantially similar to those of the 2018 Equity            
 Incentive Plan, including the treatment of awards upon change in control transactions. As of December 31, 2024, options to           
 purchase 1,647,618 shares were outstanding under the 2021 Inducement Plan. All options granted under the 2021 Inducement             
 Plan have a maximum term of seven years. Awards under the 2021 Inducement Plan may be amended by the Board at any time or            
 from time to time in accordance with the terms of the 2021 Inducement Plan and applicable law.                                       |
| (5) | The Board terminated the 2021 Inducement Plan effective as of April 3, 2022, and therefore, there                                    
 were no shares available for grant under the 2021 Inducement Plan as of December 31, 2024.                                           |

| 80 |

<div align='center'>CORPORATE GOVERNANCE</div>

CORPORATE GOVERNANCE GUIDELINES

In February 2016, our Board adopted Corporate Governance Guidelines
that set forth key principles to guide the Board in its exercise of responsibilities and serve the interests of the Company and our stockholders.
The Corporate Governance Guidelines were reviewed and updated by the Board in February 2018. Our Corporate Governance Guidelines can be
found under the header “Investors” and, within that, under the header “Corporate Governance and Compliance” of
our website at www.dynavax.com. In addition, these guidelines are available in print to any stockholder who requests a copy. Please direct
all requests to our Corporate Secretary, Dynavax Technologies Corporation, 2100 Powell Street, Suite 720, Emeryville, California 94608.

CODE OF CONDUCT

We have adopted the Dynavax Code of Business Conduct and Ethics (“Code
of Conduct”), a code of ethics that applies to our employees, including our Chief Executive Officer, Chief Financial Officer and
to our non-employee directors. The Code of Conduct is publicly available on our website under “Investors” – “